Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Mary Beth Fortugno

Member

Nashville
(615) 742-7739 TEL
(615) 248-4076 FAX

Mary Beth Fortugno

Member

Nashville
(615) 742-7739 TEL
(615) 248-4076 FAX
Nashville
(615) 742-7739 TEL
(615) 248-4076 FAX

Mary Beth Fortugno represents healthcare providers in a variety of industry sectors including four of the nation's leading hospital companies and specialty pharmacies. She focuses her practice on transactions, managed care contracting, healthcare regulatory matters, operations and investigations. Having managed matters ranging from licensure diligence and new applications to major transactions and fraud and abuse investigations, Mary Beth has built a reputation within the industry for her knowledge and operational guidance. As former operations counsel to IASIS Healthcare, an acute-care hospital company, she brings first-hand experience to healthcare clients.

Mary Beth helps clients find solutions to complex regulatory, contracting, operational and transactional issues. Her practice involves:

  • Contracting, Regulatory & Operational Matters – Counseling hospitals, specialty pharmacies and other healthcare providers on a wide range of matters related to including Anti-Kickback Statute and self-referral laws, Health Insurance Portability and Accountability Act (HIPAA), licensure, certification, managed care contracting and other operational, contracting and regulatory issues.
  • Healthcare Mergers, Acquisitions & Dispositions – Providing counsel in structuring transactions and the acquisition and disposition of healthcare providers and companies.
  • Compliance and Government Investigations – Assisting healthcare clients in responding to governmental inquiries relating to Medicare and Medicaid fraud and the False Claims Act.

Memberships

American Bar Association

American Health Lawyers Association (AHLA) — Hospitals and Health Systems Practice Group, Chair (2015-2016), Vice Chair Education (2014-2015)

Harry Phillips American Inn of Court

News

View More

Representative Experience

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Accolades

Chambers USA — Healthcare, Recognized Practitioner (2015-2016)

Best Lawyers in America® — Health Care Law (2013-2017)

Journal of Transnational Law — Associate Editor

Vanderbilt Scholastic Excellence Award — Administrative Law; Federal Tax; Professional Responsibility

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.